* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Yaron Fuchs, Ph.D. - Max Delbrück Center for Molecular Medicine
Vectors in gene therapy wikipedia , lookup
Embryonic stem cell wikipedia , lookup
Organ-on-a-chip wikipedia , lookup
Cell culture wikipedia , lookup
Stem-cell niche wikipedia , lookup
Stem-cell therapy wikipedia , lookup
Stem cell laws and policy in the United States wikipedia , lookup
Cell (biology) wikipedia , lookup
Somatic evolution in cancer wikipedia , lookup
Neuronal lineage marker wikipedia , lookup
Cellular differentiation wikipedia , lookup
Hematopoietic stem cell wikipedia , lookup
Adoptive cell transfer wikipedia , lookup
Regeneration in humans wikipedia , lookup
Somatic cell nuclear transfer wikipedia , lookup
Cell theory wikipedia , lookup
List of types of proteins wikipedia , lookup
Yaron Fuchs, Ph.D. Date of Birth 12/11/1978 Present Address: Holand 32nd Street Haifa, Israel Emails: [email protected] Telephone: +972-77-877-1691 Website: http://yfuchs.net.technion.ac.il Academic information 10.2014- Present Assistant Professor. Head, Laboratory of Stem Cell Biology and Regenerative Medicine. Lokey Interdisciplinary Center for Life Sciences & Engineering, Technion Integrated Cancer Center and The Faculty of Biology. Technion-Israel Institute of Technology. - Deloro Career Advancement Chair - Adjunct Faculty at The Rockefeller University. 2010-2014 Post-Doctoral fellow. Steller Laboratory of Apoptosis and Cancer Biology. Howard Hughes Medical Institute, The Rockefeller University. 2004- 2010 Direct Ph.D. Track for Outstanding Students. Technion-Israel Institute of Technology. 2001-2004 B.Sc. Biology. University of Haifa. Awards & Honors 1. Awarded the German-Israeli Foundation Award for Young Scientists (2017). 2. Awarded the Deloro Career advancement chair in The Leaders in Science and Technology Program. Technion-Israel Institute of Technology. Israel (2015). 3. Chosen by Rockefeller University as its candidate for the New York Academy of Science Blavatnik Award for young scientists (2014). Awards & Honors (continued) 4. Chosen by Rockefeller University as its nominee for the NIH Early Independence Primary Investigator award (2011). 5. Received the Jacobs Award for Scientific Excellence (2006). Publications -Soteriou D and Fuchs Y.*, (2016). Stem Cell Survival: The Road to Cancer is Paved with the Best Intentions. Commissioned by Nature Review Cancer (Impact factor 34.24) in preparation *corresponding author - Yosefzon Y., Soteriou D., Kostic L., Sedov E., Glaser F. and Fuchs Y.*, (2016). Caspase-3 Regulates YAP-dependent Organ Size and Skin Regeneration. Submitted to Science (Impact factor 34.66) *corresponding author - Koren E. and Fuchs Y.* (2016) The bad seed: Cancer stem cells in tumor development and resistance. Drug Resistance updates, 28, 1-12. (Impact factor 7.95) *corresponding author - Fuchs Y.* and Steller H*., (2015): Live to die another way- Modes of programmed cell death and the signals emanating from dying cells. Nature Review Molecular Cell Biology. 16,6, 329-344. (Impact factor 38.6) *corresponding author - Fuchs Y., Brown S., Gorenc T., Rodriguez J., Fuchs E. and Steller H., (2013): Sept4/ARTS regulates stem-cell apoptosis and skin regeneration. Science 341, 6143 286-289. (Impact factor 34.66) - Perez-Garijo A., Fuchs Y. and Steller H., (2013): Apoptotic cells can induce non-autonomous apoptosis through the TNF-pathway. eLife 2013, 2, e01004. (Impact factor 8.3) - Fuchs Y., Brunwasser M., Haif S., Hadad J., Shneyer B., Goldshmidt-Tran O., Korsensky L., Abed M., Zisman-Rosen S., Koren L., Carmi Y., Apte R., Yang B.R., Orian A., Bejar J., and Ron D., (2012): Sef is a novel inhibitor of pro-inflammatory cytokine signalling, acting by cytoplasmic sequestration of NF-κB. Developmental Cell 23,611-623. (Impact factor 9.3) - Fuchs Y. and Steller H., (2011): Programmed cell death in animal development and disease. Cell 147,4,742-58. (Impact factor 28.7) - Ron D., Fuchs Y., Chorev DS., (2008): Know thy Sef: a novel class of feedback antagonists of receptor tyrosine kinase signaling. Int J Biochem Cell Biol. 40,2040-52. (Impact factor 4.2) - Zisman-Rozen S., Fink D., Ben-Izhak O., Fuchs Y, Brodski A., Kraus M. H., Bejar J. and Ron D., (2007): Down-regulation of Sef, an inhibitor of receptor tyrosine kinase signalling, is common to a variety of human carcinomas. Oncogene 6,26,6093-8. (Impact factor 8.45) - Fuchs Y.#, Ziv I.#, Preger E., Shabtay A., Harduf H., Zilpa T., Dym N., Ron D., (2006): The human Sef-a isoform utilizes different mechanisms to regulate FGFR signalling pathways and subsequent cell fate. J Biol Chem. 51, 39225-35 [# Both authors equally contributed]. (Impact factor 4.5) - Fuchs Y., Douek, J., Rinkevich B., Ben-Shlomo R., (2006): Gene diversity and mode of reproduction in the brooded larvae of the coral heteroxenia fuscescens. J Hered. 5,493-8 (Impact factor 2.075) Technical publications - Kostic L., Sedov E., Soteriou D., Yosefzon Y. and Fuchs Y.*, (2016) Isolation of stem cells and progenitors from mouse epidermis. Accepted for publication Current Protocols in Stem Cell Biology. *corresponding author - Soteriou D., Kostic L., Sedov E., Yosefzon Y., Steller H.* and Fuchs Y.*, (2016) Isolation of hair follicle stem cells and epidermal keratinocytes from dorsal Mouse Skin. J. Vis Exp 29 (110), e53931, 1-6. *corresponding author